Telik reports net loss of $4.9 million for second-quarter 2010

Telik, Inc. (Nasdaq: TELK) today reported a net loss of $4.9 million, or $0.09 per share, for the second quarter ended June 30, 2010, compared with a net loss of $5.7 million, or $0.11 per share, for the comparable period in 2009.

For the quarter ended June 30, 2010, total operating costs and expenses were $5.0 million, compared with $6.3 million in the 2009 second quarter.  Operating expenses in the 2010 second quarter included stock-based compensation expense of approximately $0.4 million.  Operating expenses were approximately 21% lower in the second quarter of 2010 compared with the same period in 2009, primarily due to lower headcount and corporate administrative expenses, reduced research related expenses and lower stock compensation expense.

For the six months ended June 30, 2010, Telik reported a net loss of $10.3 million, or $0.19 per share, compared with a net loss of $13.4 million, or $0.25 per share, for the six months ended June 30, 2009.  Total operating expenses for the first six months of 2010 were $10.4 million, compared with $14.0 million for the first six months of 2009.  Operating expenses in the first six months of 2010 included approximately $1.1 million in stock-based compensation expense.  The reduction in operating expenses of approximately 26% in the first six months of 2010 compared with the same period in 2009 was primarily due to lower headcount, reduced administrative and research expenses and lower stock-based compensation expense.

At June 30, 2010, Telik had $30.8 million in cash, cash equivalents and investments including restricted investments, compared to $40.4 million at December 31, 2009.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Antibiotic activity altered by interaction with nanoplastics, new research shows